Neuroanatomy of Parkinson's disease: Changes in the neuronal cytoskeleton in only few of the susceptible cell types leads to progessive destruction of affected regions of the limbic and motor systems;Neuroanatomie des Morbus Parkinson. Veranderungen des neuronalen zytoskeletts in nur wenigen fur den krankheitsprozess empfanglichen nervenzelltypen fuhren zur progredienten zerstorung umschriebener bereiche des limbischen und des motorischen systems

Nervenarzt

Volumn 71, Issue 6, 2000, Pages 459-469

  Braak, H ^a   Rub U ^a   Braak, E ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Synuclein; Cytoskeleton; Lewy bodies; Lewy neurites; Limbic system; Motor system; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN;

CYTOSKELETON; HUMAN; INTESTINE INNERVATION; LEWY BODY; LIMBIC SYSTEM; MOTOR SYSTEM; NEUROANATOMY; NEUROPATHOLOGY; PARKINSON DISEASE; PERIKARYON; REVIEW; APOPTOSIS; AUTONOMIC NERVOUS SYSTEM; BRAIN; MOTOR CORTEX; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; ULTRASTRUCTURE;

APOPTOSIS; AUTONOMIC NERVOUS SYSTEM; BRAIN; CYTOSKELETON; HUMANS; LEWY BODIES; LIMBIC SYSTEM; MOTOR CORTEX; NEURONS; PARKINSON DISEASE;

EID: 0343081430     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150050607     Document Type: Review

References (70)

1. Agid Y, Ruberg M, Javoy-Agid F et al. (1993) Are dopaminergic neurons selectively vulnerable to Parkinson's disease. Adv Neurol 60:148-164
2. Alexander GE, Crutcher MD, DeLong MR (1990) Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, 'prefrontal' and 'limbic' functions. Prog Brain Res 85:119-146
3. Alheid GF, Heimer L, Switzer RC (1990) Basal ganglia. In: Paxinos G (ed) The human nervous system. Academic Press, San Diego, pp 483-582
4. Baba M, Nakajo S, Tu PH et al. (1998) Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 152:879-884
5. Bancher C, Lassmann H, Budka H et al. (1989) An antigenic profile of Lewy bodies: immunocytochemical indication for protein phosphorylation and ubiquitination. J Neuropathol Exp Neurol 48:81-93
6. Bergeron C, Pollanen MS (1996) Pathogenesis of the Lewy body. In: Perry R, Mc Keith I, Perry E (eds) Dementia with Lewy bodies. Cambridge Univ Press, New York, pp 302-308
7. Braak E, Braak H (1999) Silver staining method for demonstrating Lewy bodies in Parkinson's disease and argyrophilic oligodendrocytes in multiple system atrophy. J Neurosci Methods 87:111-115
8. Braak H (1980) Architectonics of the human telencephalic cortex. In: Braitenberg V, Barlow HB, Bizzi E, Florey E, Grüsser OJ, van der Loos H (eds) Studies of brain function. Springer, Berlin Heidelberg New York, pp 1-147
9. Braak H, Braak E (1986) Nuclear configuration and neuronal types of the nucleus niger in the human adult. Human Neurobiol 5:71-82
10. Braak H, Braak E (1992) The human entorhinal cortex: Normal morphology and lamina-specific pathology in various diseases. Neurosci Res 15:6-31
11. Braak H, Braak E (1993) Anatomy of the human basal ganglia. In: Szelenyi I (ed) Inhibitors of monoamine oxidase B. Birkhäuser, Basel, pp 3-23
12. Braak H, Braak E, Yilmazer D, De Vos RAI, Jansen ENH, Bohl J, Jellinger K (1994) Amygdala pathology in Parkinson's disease. Acta Neuropathol 88:493-500
13. Braak H, Braak E, Yilmazer D, Schultz C, De Vos RAI, Jansen ENH (1995) Nigral and extranigral pathology in Parkinson's disease. J Neural Transm 46:15-31
14. Braak H, De Vos RAI, Jansen ENH, Bratzke H, Braak E (1998) Neuropathological hallmarks of Alzheimer's and Parkinson's diseases. Prog Brain Res 117:267-285
15. Braak H, Sandmann-Keil D, Gai WP, Braak E (1999) Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by α-synuclein immunocytochemistry. Neurosci Lett 265:67-69
16. Den Hartog Jager WA, Bethlem J (1960) The distribution of Lewy bodies in the central and autonomic nervous systems in idiopathic paralysis agitans. J Neurol Neurosurg Psychiatry 23:283-290
17. Deuschl G (1995) Grundprinzipien der Differentialdiagnose und Differentialtherapie des Morbus Parkinson. In: Deuschl G (ed) Morbus Parkinson. α-Dihydroergocryptin -ein neuer Dopamin-Agonist. Thieme, Stuttgart, S 1-15
18. Dickson DW, Schmidt ML, Lee VMY, Zhao ML, Yen SH, Trojanowski JQ (1994) Immunoreactivity profile of hippocampal CA2/3 neurites in diffuse Lewy body disease. Acta Neuropathol 87:269-276
19. Fallon JH, Loughlin SE (1987) Monoamine innervation of cerebral cortex and a theory of the role of monoamines in cerebral cortex and basal ganglia. In: Peters A, Jones EG (eds) Cerebral cortex. Vol 6. Further aspects of cortical function, including hippocampus. Plenum Press, New York, pp 41-127
20. Fearnley JM, Lees AJ (1991) Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114:2283-2301
21. Fearnley JM, Lees AJ (1994) Pathology of Parkinson's disease. In: Calne DB (ed) Neurodegenerative diseases. Saunders, Philadelphia, pp 545-554
22. Forno LS (1996) Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 55:259-272
23. Gai WP, Blessing WW, Blumbergs PC (1995) Ubiquitin-positive degenerating neurites in the brainstem in Parkinson's disease. Brain 118:1447-1459
24. Gai WP, Blumbergs PC, Blessing WW (1996) Microtubule-associated protein 5 is a component of Lewy bodies and Lewy neurites in the brainstem and forebrain regions affected in Parkinson's disease. Acta Neuropathol 91:78-81
25. Gibb WRG (1991) Neuropathology of the substantia nigra. Eur Neurol 31:48-59
26. Gibb WRG, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51:745-752
27. Gibb WRG, Lees AJ (1989) The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease. Neuropathol Appl Neurobiol 15:27-44
28. Gibb WRG, Lees AJ (1991) Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J Neurol Neurosurg Psychiatry 54:388-396
29. Goedert M (1997) The awakening of α-synuclein. Nature 388:232-233
30. Goto S, Hirano A (1991) Catecholaminergic neurons in the parabrachial nucleus of normal individuals and patients with idiopathic Parkinson's disease. Ann Neurol 30:192-196
31. Halliday GM, Li YW, Blumbergs PC, Joh TH, Cotton RGH, Howe PRC, Blessing WW, Geffen LB (1990) Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease. Ann Neurol 27:373-385
32. Hassler R (1938) Zur Pathologie der Paralysis agitans und des postenzephalitischen Parkinsonismus. J Psychol Neurol 48:387-476
33. Heimer L, De Olmos J, Alheid GF, Zaborszky L (1991) "Perestroika" in the basal forebrain: Opening the border between neurology and psychiatry. Prog Brain Res 87:109-165
34. Hellenbrand W, Vieregge P, Robra BP et al. (1993) Die Ätiologie des Morbus Parkinson. Eine epidemiologische Perspektive mit möglichen Implikationen für die Prävention. Nervenarzt 64:770-786
35. Hirsch EC, Graybiel AM, Agid YA (1988) Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 334:345-347
36. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181-184
37. Irizarry MC, Growdon W, Gomez-Isla T, Newell K, George JM, Clayton DF, Hyman BT (1998) Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy bodies disease contain α-synuclein immunoreactivity. J Neuropathol Exp Neurol 57:334-337
38. Iwatsubo T, Yamaguchi H, Fujimuro M, Yokosawa H, Ihara Y, Trojanowski JQ, Lee VM (1996) Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease. Am J Pathol 148:1517-1529
39. Jellinger K (1987) The pathology of parkinsonism. In: Marsden CD, Fahn S (eds) Movement disorders 2. Butterworths, London, pp 124-165
40. Jellinger K (1991) Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway. Mol Chem Neuropathol 14:153-197
41. Koller WC (1992) How accurately can Parkinson's disease be diagnosed? Neurology 42:6-16
42. Langston JW, Forno LS (1978) The hypothalamus in Parkinson disease. Ann Neurol 3:129-133
43. Leigh PN, Probst A, Dale GE, Power DP, Brion JP, Dodson A, Anderton BH (1989) New aspects of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodies. Acta Neuropathol 79:61-72
44. Lennox G, Lowe J, Landon M, Byrne EJ, Mayer RJ, Godwin-Austen RB (1989) Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry. J Neurol Neurosurg Psychiatry 52:1236-1247
45. Lewy FH (1912) Paralysis agitans. I. Pathologische Anatomie. In: Lewandowski M (Hrsg) Handbuch der Neurologie. Springer, Berlin, pp 920-933
46. Lewy FH (1913) Zur pathologischen Anatomie der Paralysis agitans. Dtsch Z Nervheilkd 50:50-55
47. Lewy FH (1923) Die Lehre vom Tonus und der Bewegung, zugleich systematische Untersuchungen zur Klinik, Physiologie, Pathologie und Pathogenese der Paralysis agitans. Springer, Berlin
48. Lowe J (1994) Lewy bodies. In: Calne DP (ed) Neurodegenerative diseases. Saunders, Philadelphia, pp 51-69
49. Malessa S, Hirsch EC, Cervera P, Duyckaerts C, Agid Y (1990) Catecholaminergic systems in the medulla oblongata in parkinsonian syndromes: a quantitative immunohistochemical study in Parkinson's disease, progressive supranuclear palsy, and striatonigral degeneration. Neurology 40:1739-1743
50. Matzuk MM, Saper CB (1985) Preservation of hypothalamic dopaminergic neurons in Parkinson's disease. Ann Neurol 18:552-555
51. Nauta WJH (1986) Circuitous connections linking cerebral cortex, limbic system, and corpus striatum. In: Doane BK, Livingstone KE (eds) The limbic system. Raven Press, New York, pp 43-54
52. Nieuwenhuys R (1996) The greater limbic system, the emotional motor system and the brain. Prog Brain Res 107:551-580
53. Oades RD, Halliday GM (1987) Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity. Brain Res Rev 12:117-165
54. Ohama E, Ikuta F (1976) Parkinson's disease: distribution of Lewy bodies and monoamine neuron system. Acta Neuropathol 34:311-319
55. Panula P, Airaksinen MS, Pirvola U, Kotilainen E (1990) A histamin-containing neuronal system in human brain. Neuroscience 34:127-132
56. Parent A, Hazrati LN (1995) Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortkal loop. Brain Res Rev 20:91-127
57. Pearson J, Halliday G, Sakamoto N, Michel JP (1990) Catecholaminergic neurons. In: Paxinos G (ed) The human nervous system. Academic Press, San Diego, pp 1023-1049
58. Poewe W, Oertel W (1992) Neue Entwicklungen in Diagnostik, Klinik und Therapie des Parkinson-Syndroms. In: Elger CE, Dengler R (Hrsg) Jahrbuch der Neurologie. Biermann, Zülpich, S 115-135
59. Pollanen MS, Dickson DW, Bergeron C (1993) Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 52:183-191
60. Sandmann-Keil D, Braak H, Okochi M, Haass C, Braak E (1999) Alpha-synuclein immunoreactive Lewy bodies and Lewy neurites in Parkinson's disease are detectable by an advanced silver-staining technique. Acta Neuropathol 98:461-464
61. Saper CB (1990) Cholinergic system. In: Paxinos G (ed) The human nervous system. Academic Press, San Diego, pp 1095-1113
62. Saper CB, Sorrentino DM, German DC, de Lacalle S (1991) Medullary catecholaminergic neurons in the normal human brain and in Parkinson's disease. Ann Neurol 29:577-584
63. Schneider E (1997) Diagnostik und Therapie des Morbus Parkinson. De Gruyter, Berlin New York
64. Schneider E (1999) Autonome Störungen bei der Parkinson-Krankheit und deren Behandlung. Nervenarzt [Suppl] 70:26-34
65. Scholz E, Oertel WH (1993) Parkinson-Syndrome. In: Brandt T, Dichgans J, Diener HC (Hrsg) Therapie und Verlauf neurologischer Erkrankungen, 2. Aufl. Kohlhammer, Stuttgart, S 927-968
66. Spillantini MG, Schmidt ML, Lee VMY, Trojanowski JQ, Jakes R, Goedert M (1997) α-Synuclein in Lewy bodies. Nature 388:839-840
67. Törk I, Hornung JP (1990) Raphe nuclei and the serotoninergic system. In: Paxinos G (ed) The human nervous system. Academic Press, San Diego, pp 1001-1022
68. Trojanowski JQ, Lee VMY (1998) Aggregation of neurofilament and α-synuclein proteins in Lewy bodies - implications for the pathogenesis of Parkinson disease and Lewy body dementia. Arch Neurol 55:151-152
69. Wakabayashi K, Matsumoto K, Takayama K, Yoshimoto M, Takahashi A (1997) NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease. Neurosci Lett 239:45-48
70. Zilles K (1990) Cortex. In: Paxinos G (ed) The human nervous system. Academic Press, San Diego, pp 757-802